Opioid Maker Payments to Doctors; Sunshine Data Promotes Valuable Analysis
Aug 10, 2017
Sen. Chuck Grassley is the co-author of the Physician Payments Sunshine Act disclosure requirements for drug company payments to doctors. He is also the co-sponsor of pending bipartisan legislation to apply the disclosure requirements to nurse practitioners and physician assistants. Grassley made the following comment on a new study finding that according to the sunshine data, about one in 12 doctors received a payment involving an opioid during the 29-month study, totaling $46.2 million. Grassley made the following comment on the study.
“This is exactly the kind of research the sunshine disclosures should promote. Payments don’t mean doctors are doing something wrong. Disclosure allows for the analysis of trends, like the fact that opioid makers were reaching a lot of doctors as the opioid crisis was getting worse. This is information the public should know.”